FDA's secret OTC Epinephrine plan revealed?

An intriguing perspective emerges on the recent regulatory environment surrounding epinephrine. The intense advocacy group pressure, highlighted by the extensive Duke town hall, suggests a deliberate, cautious approach from the FDA. Observers speculate this move is a crucial pilot program to gauge public readiness and manage the shift toward broader over the counter availability, making the stakes incredibly high for the agency to get it right.
#Epinephrine #OTC #FDA #DrugAccess #HealthcarePolicy #PilotProgram #Advocacy

Видео FDA's secret OTC Epinephrine plan revealed? канала Dan Sfera